References
- Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997;315:1219-22. https://doi.org/10.1136/bmj.315.7117.1219
- Suh SY, Choi YS, Shim JY, Kim YS, Yeom CH, Kim D, et al. Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer 2010; 18:151-7. https://doi.org/10.1007/s00520-009-0639-x
- Chow E, Harth T, Hruby G, Finkelstein J, Wu J, Danjoux C. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol) 2001;13:209-18.
- Vigano A, Donaldson N, Higginson IJ, Bruera E, Mahmud S, Suarez-Almazor M. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 2004;101:1090-8. https://doi.org/10.1002/cncr.20472
- Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC. Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 1993;7:199-204. https://doi.org/10.1177/026921639300700306
- Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 1992;7:82-6. https://doi.org/10.1016/0885-3924(92)90118-2
- Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. ltalian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 1999;17:231-9. https://doi.org/10.1016/S0885-3924(98)00145-6
- Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004;80:299-307.
- Engel JH, Siewerdt F, Jackson R, Akobundu U, Wait C, Sahyoun N. Hardiness, depression, and emotional well-being and their association with appetite in older adults. J Am Geriatr Soc 2011;59:482-7. https://doi.org/10.1111/j.1532-5415.2010.03274.x
- Caliskan Y, Yelken B, Gorgulu N, Ozkok A, Yazici H, Telci A, et al. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants. J Ren Nutr 2012;22:258-67. https://doi.org/10.1053/j.jrn.2011.07.005
- Robertson MD, Henderson RA, Vist GE, Rumsey RD. Plasma ghrelin response following a period of acute overfeeding in normal weight men. Int J Obes Relat Metab Disord 2004;28:727-33. https://doi.org/10.1038/sj.ijo.0802637
- Smiechowska J, Utech A, Taffet G, Hayes T, Marcelli M, Garcia JM. Adipokines in patients with cancer anorexia and cachexia. J Iinvesting Med 2010;58:554-9. https://doi.org/10.2310/JIM.0b013e3181cf91ca
- Geissbuhler P, Mermillod B, Rapin CH. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage 2000;20:93-103. https://doi.org/10.1016/S0885-3924(00)00169-X
- McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001;41:64-9. https://doi.org/10.1080/01635581.2001.9680613
- Bottcher Y, Teupser D, Enigk B, Berndt J, Kloting N, Schon MR, et al. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 2006;91:2725-31. https://doi.org/10.1210/jc.2006-0149
- Blakemore AI, Meyre D, Delplanque J, Vatin V, Lecoeur C, Marre M, et al. A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity. Obesity (Silver Spring) 2009;17:1549-53. https://doi.org/10.1038/oby.2009.75
- Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-30. https://doi.org/10.1126/science.1097243
-
Olszanecka-Glinianowicz M, Kocelak P, Janowska J, Skorupa A, Nylec M, Zahorska-Markiewicz B. Plasma visfatin and tumor necrosis factor-alpha (TNF-
$\alpha$ ) levels in metabolic syndrome. Kardiol Pol 2011;69:802-7. - Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, et al. Elevated plasma level of visfatin/pre-B cell colony enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-9. https://doi.org/10.1210/jc.2005-1475
- Lajunen TK, Purhonen AK, Haapea M, Ruokonen A, Puukka K, Hartikainen AL, et al. Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome. Eur J Clin Invest 2012;42:321-8. https://doi.org/10.1111/j.1365-2362.2011.02586.x
- Carrero JJ, Witasp A, Stenvinkel P, Qureshi AR, Heimburger O, Barany P, et al. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. Nephrol Dial Transplant 2010;25:901-6. https://doi.org/10.1093/ndt/gfp587
- Cline MA, Nandar W, Prall BC, Bowden CN, Denbow DM. Central visfatin causes orexigenic effects in chicks. Behav Brain Res 2008;186:293-7. https://doi.org/10.1016/j.bbr.2007.08.016
- Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007;85:399-404.
- Kovacikova M, Vitkova M, Klimcakova E, Polak J, Hejnova J, Bajzova M, et al. Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction. Eur J Clin Invest 2008;38:516-22. https://doi.org/10.1111/j.1365-2362.2008.01964.x
- Hallschmid M, Randeva H, Tan BK, Kern W, Lehnert H. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diagetes 2009;58:637-40.
- Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998;279:1709-14. https://doi.org/10.1001/jama.279.21.1709
- Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 1999;7:128-33. https://doi.org/10.1007/s005200050242
- Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, et al. Prediction of survival of patients terminally ill with cancer: Results of an ltalian prospective multicentric study. Cancer 1995;75:2613-22. https://doi.org/10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1
- Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch lntern Med 1988;148:1586-91. https://doi.org/10.1001/archinte.1988.00380070082020
- Sungurtekin H, Sungurtekin U, Hanci V, Erdem E. Comparison of two nutrition assessment techniques in hospitalized patients. Nutrition 2004;20:428-32. https://doi.org/10.1016/j.nut.2004.01.006
- Zabel R, Ash S, King N, Bauer J. The relationship between subjective appetite sensations, markers of inflammation and appetite in dialysis patients. J Hum Nutr Diet 2009;22:343-50. https://doi.org/10.1111/j.1365-277X.2009.00968.x
Cited by
- The Relationship between Opioids Use, Cortisol and DHEAS vol.18, pp.2, 2015, https://doi.org/10.14475/kjhpc.2015.18.2.105